MediWound posts earnings miss, revenue beats forecasts
Medical products firm MediWound reported adjusted earnings below expectations but revenue above estimates for the latest quarter.
MediWound reported adjusted earnings per share that fell short of analyst forecasts for the second quarter, while revenue exceeded market projections.
The company, which develops advanced wound care products, said adjusted earnings came in at $0.03 per share, missing the consensus estimate of $0.06 per share. Revenue totaled $12.4 million, topping the $11.8 million forecast by analysts surveyed by Refinitiv.
MediWound attributed the earnings shortfall to higher research and development costs, as well as increased expenses related to commercial operations. The company did not provide updated guidance for the full year, citing ongoing market uncertainties and supply chain challenges.
Shares of MediWound were down 5% in after-hours trading following the release of the results.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →